Day: September 17, 2025

SAN JUAN, Puerto Rico, Sept. 17, 2025 (GLOBE NEWSWIRE) — Red Cat Holdings, Inc. (Nasdaq: RCAT) (“Red Cat” or “Company”), a drone technology company integrating robotic hardware and software for military, government, and commercial operations, announced today that it intends to offer and sell shares of its common stock in an underwritten public offering. In connection with the offering, Red Cat also expects to grant the underwriter a 30-day option to purchase up to an additional 15% of the shares of common stock offered in the public offering. The offering is subject to market and other conditions, and there can be no assurance as to whether or when the offering may be completed, or as to the actual size or terms of the offering. The Company intends to use net proceeds from the offering for general corporate and working capital...

HOUSTON, Sept. 17, 2025 (GLOBE NEWSWIRE) — Kayne Anderson Energy Infrastructure Fund, Inc. (the “Company”) (NYSE: KYN) announced today that it reached an agreement with institutional investors relating to a private placement of $100 million of senior unsecured notes (“Notes”). The private placement is expected to close on or about October 15, 2025. Net proceeds will be used to refinance existing leverage and for general corporate purposes. The table below sets forth the key terms of the Notes to be issued.Notes Series Amount ($ in millions) Fixed Rate MaturityAAA $60 4.43% October 2028BBB $40 4.60% October 2030Closing of this transaction is subject to investor due diligence, legal documentation, and other standard closing conditions. The Notes issued in connection with this private placement will not be registered under...

SAN RAMON, Calif., Sept. 17, 2025 (GLOBE NEWSWIRE) — CooperCompanies (Nasdaq: COO), a leading global medical device company, announced today its Board of Directors has approved a $1 billion increase in the Company’s share repurchase program. The share repurchase program now totals $2 billion. “We are pleased to announce that our Board of Directors has authorized an increase to our share repurchase program,” said Al White, President and Chief Executive Officer. “This decision underscores the strength of our balance sheet and cash flow generation, and reflects the Board’s continued confidence in Cooper’s long-term growth trajectory. Returning capital to our shareholders through share repurchases—while continuing to invest and reduce debt—remains aligned with our disciplined capital allocation strategy and commitment to enhancing...

CAMBRIDGE, Mass., Sept. 17, 2025 (GLOBE NEWSWIRE) — Vor Bio (Nasdaq: VOR), a clinical-stage biotechnology company transforming the treatment of autoimmune diseases, today announced that 48-week clinical data from the Phase 3 study in China evaluating telitacicept in adults with generalized myasthenia gravis, a study sponsored by Vor’s collaborator RemeGen Co., Ltd (HKEX: 9995, SHA: 688331), will be presented as an oral presentation at the American Association of Neuromuscular & Electrodiagnostic Medicine Annual Meeting, being held October 29 to November 1, 2025, at the Hilton San Francisco Union Square in San Francisco, California. Oral Presentation DetailsAbstract Title: Efficacy and Safety of Telitacicept in Patients with Generalized Myasthenia Gravis: Results from a Phase 3 StudySession: MGFA (Myasthenia Gravis Foundation...

NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES CALGARY, Alberta, Sept. 17, 2025 (GLOBE NEWSWIRE) — Global Uranium Corp. (CSE: GURN | FRA: Q3J) (the “Company”) announces, that it has amended the terms of its previously announced financing under the Listed Issuer Financing Exemption (the “Offering”) to increase the minimum amount to be raised under the Offering to C$1,500,000. Under the Offering, as amended, the Company intends to complete a non-brokered private placement financing (the “Amended Offering”), pursuant to the “listed issuer financing exemption” under Part 5A of National Instrument 45-106 – Prospectus Exemptions, as amended by Coordinated Blanket Order 45- 935 – Exemptions from Certain Conditions of the Listed Issuer Financing Exemption (the “Listed Issuer Financing...

Data show a favorable safety profile and early efficacy signals in a heavily pre-treated population whose cancer progressed after multiple prior lines of therapy including anti-PD-1 Recommended phase 2 dose (RP2D) established at 33% of gross tumor volume (GTV) 47.4% (9/19) best observed objective response rate (ORR) in all lesions per RECIST 1.1 78.9% (15/19) best observed disease control rate (DCR) in all lesions per RECIST 1.1 14.6 months median Overall Survival (mOS) in all patients treated (n=21) Investigators concluded that these data warrant further investigation in randomized clinical trials as a potential new option for patients with primary cutaneous melanoma naïve or refractory to anti-PD-1 Nanobiotix will host a conference call to discuss the data on September 18, 2025 at 8:00AM EDT/ 2:00PM CESTData presented on September...

Atlanta, GA, Sept. 17, 2025 (GLOBE NEWSWIRE) — Regional Health Properties, Inc. (“Regional”) (OTCQB: RHEP) (OTCQB: RHEPA) (OTCQB: RHEPB) (OTCQB: RHEPZ) today announced it has completed the repurchase of 366,359 shares of its 12.5% Series B Cumulative Redeemable Preferred shares through three privately negotiated transactions. “The recently closed merger with SunLink Health Systems was a transformative step for Regional Health Properties. We are excited to use a portion of the excess cash obtained in the merger to repurchase our Series B Preferred shares at a significant discount to the liquidation preference,” said Brent S. Morrison, Chairman and Chief Executive Officer of Regional. After these repurchases, 1,885,913 shares of Series B Preferred remain outstanding.  About Regional Health Properties, Inc. Regional Health Properties,...

DUNMORE, Pa., Sept. 17, 2025 (GLOBE NEWSWIRE) — Fidelity D & D Bancorp, Inc. (NASDAQ: FDBC) (“Fidelity Bank”), the parent bank holding company of The Fidelity Deposit and Discount Bank (“Fidelity Bank”), a Pennsylvania state-chartered, FDIC-insured community bank and trust company headquartered in Dunmore, PA, announces the retirement of Director Richard Hotchkiss effective September 16th, 2025. Mr. Hotchkiss was appointed to the Fidelity Bank Board of Directors on May 5, 2020, following the merger with MNB Corporation and its wholly owned subsidiary, Merchants Bank of Bangor. He has served as Chair of the Lehigh Valley Advisory Board, a position in which he will continue, and has also held the role of Chair of the Credit Administration Committee. Before joining Fidelity Bank, he was appointed Director and Vice President of...